Kucher A, Gaitán C, Skinner M, Cruz M, Escobar A, Alfonso O, Iorio A, germini F, Parrish R, Sevestre M. LR-07.01 (1160466) Integration of the Mexican Registry of Coagulopathies (RMC) with PROBE. (2022), Abstracts. Haemophilia, 28: 5-97. https://doi.org/10.1111/hae.14537
Introduction
Registro Mexicano de Coagulopatías (RMC) is a national registry app connected to the Federation of Hemophilia of the Mexican Republic (FHRM) for people living with hemophilia (PWH) or other bleeding disorders or caregivers to report infusions and bleeds. Patient Reported Outcomes Burdens and Experiences Study (PROBE) is a validated global patient-reported quality of life questionnaire for PWH or individuals without a bleeding disorder available in app (myPROBE), web, or paper format. These two tools were linked such that the RMC login can be used to access PROBE using a single sign-on (SSO) authentication scheme.RMC users are followed longitudinally, receive yearly reminders to complete PROBE, and receive reports on changes to their PROBE score. This connectivity will make data collection more user-friendly, useful and efficient; provide personal health information feedback; and increase the number of people reporting without the need for dual reporting.
Methods
The Health Information Research Unit team at McMaster University and Design2Code Inc. developed an online survey using Windows.net and React Native technologies and implemented the OAuth 2 Client protocol in PROBE while FHRM implemented OAuth 2 Server in RMC. OAuth 2 is the authentication protocol that allows for SSO.
Results
In February 2020, RMC and PROBE developed a linkage between the two data sets for the online platform and mobile application (iOS and Android). In October 2020 the collaboration went live with a soft launch, allowing RMC users to take the PROBE survey using RMC. The applications have a WebView where the PROBE website is loaded and the users sign in with their RMC credentials. To date 32 PWH have initiated data collection.
Conclusions
The number of PWH reporting annually via PROBE will increase, revealing individual and population-level changes. With the demonstrated functionality and successful integration, plans are underway for wider rollout and promotion. The collaboration will provide the FHRM with valuable patient-reported outcome data on pain, education and employment, need for mobility aids, and impact of hemophilia on activities of daily living. These data in combination with data from the PROBE global data set may be used to support further access and improvements in clinical and patient outcomes.
View Presentation: Integration of the Mexican Registry
